Cleared Traditional

K133925 - VYNTUS/ SENTRYSUITE PRODUCT LINE

K133925 is an FDA 510(k) clearance for VYNTUS/ SENTRYSUITE PRODUCT LINE, manufactured by Carefusion Germany 234 GmbH. The device is a Class 2 Anesthesiology device with product code BZC cleared through the Traditional 510(k) pathway after a 242-day FDA review.

K133925 · Carefusion Germany 234 GmbH · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
242d
Days
Class 2
Risk

K133925 is an FDA 510(k) clearance for the VYNTUS/ SENTRYSUITE PRODUCT LINE. Classified as Calculator, Pulmonary Function Data (product code BZC), Class II - Special Controls.

Submitted by Carefusion Germany 234 GmbH (Hoechberg, DE). The FDA issued a Cleared decision on August 22, 2014 after a review of 242 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1880 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K133925

510(k) Number K133925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2013
Decision Date August 22, 2014
Days to Decision 242 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 140d · This submission: 242d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZC Device Classification - Class 2, Special Controls

Product Code BZC Calculator, Pulmonary Function Data
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZC Calculator, Pulmonary Function Data

All 53
Devices cleared under the same product code (BZC) and FDA review panel - the closest regulatory comparables to K133925.
COSMED K5 Wearable Metabolic Technology
K162515 · Cosmed Srl · Jun 2017
MiniBox +
K161295 · Pulmone Advanced Medical Devices, Ltd. · Oct 2016
Vyntus / SentrySuite Product Line
K150810 · Carefusion Germany 234 GmbH · Aug 2015
PULMONE MINIBOX PFT TM
K133051 · Pulmone Advanced Medical Devices, Ltd. · May 2014
LCI OPTION FOR INNOCOR
K102047 · Innovision A/S · Nov 2011
MASTERSCREEN & OXYCON CPX
K072323 · Viasys Healthcare GmbH · Oct 2007